Conferences and Meetings on Infectious Disease Medicine

End Hep C SF envisions a San Francisco where hepatitis C is no longer a public health threat, and hepatitis C-related health inequities have been eliminated. We know that strong research, collection and use of data, and dissemination of findings is key to our ability to eliminate hepatitis C in our city. This symposium will showcase the various studies and programs End Hep C SF partners have initiated in order to better understand the local HCV epidemic and the initiative’s progress toward elimination. We look forward to celebrating End Hep C SF and its partners' accomplishments, and looking ahead toward the next steps in the HCV elimination process. Note that although registration is free, space is limited. Attendees are encouraged to register early and please cancel if no longer able to attend. Lunch will be provided.

Email: info@endhepcsf.org

Abstract submission:

Research abstracts (Basic Science, Clinical Science, Case

Reports, Social/Behavioral Science, Epidemiology/Public

Health and Translational Research) in the following broad

fields are invited:

• HIV / AIDS

• Sexually Transmitted Infections (STIs)

• Tuberculosis (TB)

• Viral hepatitis

• Other infectious diseases

Highlights:

• Eminent international speakers.

• Certificate of participation with CME credits

accredited by Medical University / Medical Council.

• The abstracts presented will be published in the

indexed journal, BMC Infectious Diseases

with Impact Factor 2.62.

Symposium Secretariat:

YRG CARE

No. 34, East Street, Kilpauk Garden

Chennai-600010, INDIA.

Phone: +91-44-22542254

Email: ISSHID2019@yrgcare.org

Phone: [+917667444221];     Email: bala@yrgcare.org

HIV, AIDS, HIV/AIDS, Infectious diseases, HBV, HCV, TB, Tuberculosis, ISSHID, ISSHID 2019, YRG CARE, SRIHER,

Welcome to Global Conference on Virology & Vaccines is going to be scheduled for October 14-16, 2019 in Osaka, Japan. This exciting symposium will provide you with an overview of significant areas in Virology & Vaccines research, varying from Viral Infections to T cell Activation & Gene editing. These subject areas will form the core of the scientific program that is initiated by overviews of Virus interactions with the host and is closed with an outlook on the future.

Phone: [+0034518889990];     Email: secretary.osaka@virologycongress.com

Immunology, Vaccines, Microbiology

This acclaimed Harvard Medical School CME course provides a comprehensive ID update. Led by Harvard Medical School's leading ID faculty and clinicians, this program provides guidance to improve the diagnosis, prevention, and treatment of infectious diseases. Participants learn the practice implications of important new innovations and ensure that their ability to address ID challenges is fully current.

Phone: [617-384-8600];     Email: CEPrograms@hms.harvard.edu

Harvard, CME, Immunizations, Lyme, infection, vaccine, HIV, MRSA, Hepatitis, UTIs, STIs, zoster, flu, gastroenteritis, travel medicine, respiratory

Malaria is most prevalent in the tropical belt and many malaria endemic countries have now engaged in elimination programs. However, we are facing a public health crisis because we have lost many of the public health tools that enabled the progress we have made to date. Many drugs are useless in most areas and resistance is threatening even artemisinin-based combination therapy (ACT). Diagnostics, bed-nets and insecticides are also losing their effectiveness and the Plasmodium vivax (P. vivax) parasite is finding new ways to transmit in Duffy negative patients. At the same time, there are multiple emerging threats such as artemisinin drug resistance, the rise of P. vivax malaria prevalence, and the discovery of the parasite Plasmodium knowlesi (P. knowlesi) in humans. However, there are some interesting developments such as deploying older suboptimal drugs in new, innovative and targeted control approaches like seasonal malaria chemoprevention (SMC) or intermittent preventive treatment of pregnant women/ infants (PTi/p). There are new drugs on the horizon that have pharmacological properties compatible with single dose cures and could prove to be powerful tools in the fight against malaria. For example, mass drug administration has demonstrated substantial impact as an intervention for Plasmodium elimination. By learning from recent successes in malaria elimination, epidemiological models of malaria transmission can be updated, and the impact of new interventions will critically inform the malaria endgame strategy. The conference is organized around three themes: defeating resistance (both to drugs and to insecticides), leveraging data science to better understand disease transmission and innovation in vector control strategies. This program will assess the current threats and gaps in our malaria armamentarium to enable malaria elimination and discuss the emerging innovative approaches for antimalarial drug discovery and development.

Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org

malaria, infectious diseases, mosquito-borne illness

Immunology and Allergic Diseases,    Biology

Our twelfth international conference brings together world leading experts to share the latest advances and discuss the challenges of defeating meningitis and septicaemia. Around 300 delegates from a range of specialties and international institutions will join us at The British Museum for two days of presentations from renowned leaders in their field, lively panel discussions and poster presentations that showcase talent, in-depth knowledge and cutting-edge research. This key event for world leading authorities in infectious disease, paediatrics, public health, vaccinology and global health medicine also offers excellent opportunities to network and share opinions.

Phone: [0333 405 6262];     Email: elizabethr@meningitis.org

Meningitis, Septicaemia, Sepsis, Infectious disease, Public health, Global Public Health

Epidemiology & Public Health,    Pediatrics

The joint congress of ‘31st International congress of Antimicrobial Chemotherapy (ICC) and 4th Gulf Congress of Clinical Microbiology & infectious Diseases (GCCMID) 2019’ will be held in Dubai International Convention and Exhibition Centre (DICEC), UAE from 6 - 9 November 2019. 31st ICC-4th GCCMID 2019 promises to provide exceptional opportunity for everyone to share & acquire knowledge, through a rich educational and scientific setting, covering the latest advances in research and practice through presentations, workshops and discussions with in-depth high quality scientific contents and lectures on infectious diseases, antimicrobial chemotherapy, infection control, and clinical microbiology. We invite all experts including Infectious Diseases Specialist, Microbiologist, Epidemiologist, Public Health Researchers, Infection Control Professionals etc to submit your research work and become a part of this international conference.

Phone: [+971559145907];     Email: soumya@meetingmindsdubai.com

Infection Prevention and Control, Virology, HIV, Infections in IC, Molecular Biology, Antimicrobial Resistance, Zoonosis, Mycrobacterial Infections, Transplant infectious complications, Vaccination, Clinical Pharmacy, Research, Clinical Microbiology, Antimicrobial Chemotherapy, CME Conferences, Dubai International Convention and Exhibition Center, Dubai Conferences

Molecular Biology,    Continuing Medical Education (CME)

It takes us immense pleasure to announce the conference that is "Epidemiology and Public Health" which is going to be held from November 11-12, 2019 at, Netherlands. Epidemiology and Public Health conference will focus on the latest and exciting innovations in all areas of Epidemic research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Insights of Public Health for a Healthy Mankind” which reflects the innovative progress in Public Health research.

Phone: [+35982518874];     Email: epidemiology19@gmail.com

Epidemiology, Epidemics, Public Health, Health care, Infectious Disease, Nursing, Midwifery, Psychological Health, Dental Care, Environmental Epidemics,

Epidemiology & Public Health,    Healthcare Systems and Hospital Management

Parasitic worms, or helminths, infect roughly one in five people on the planet and cause pathology in hundreds of millions. Given the global impact on human health and welfare, there is a great need to develop novel therapies and/or vaccines that target helminths. In addition, the unique nature of how these parasites interact with their hosts has brought tremendous insight into the mammalian immune system. Experimental studies of helminth infection have led to the identification of new cell types involved in type 2 immunity, including innate lymphoid cells, tuft cells, and new roles for neurons, in addition to revealing novel pathways of tissue repair and immune-modulation. The interactions of helminths with the microbiome has also come to light in recent years. This conference will highlight some of the most impactful advances in the fields of helminth genomics, helminth biology, vaccine design and host protective immunity, in addition to new discoveries highlighting the ability of these organisms to modulate the immune system, human disease and the microbiome.

Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org

parasitology, infectious diseases, immunology, helminths, parasitic worms

Epidemiology & Public Health,    Immunology and Allergic Diseases

Biology,    Molecular Biology

Biology,    Molecular Biology

The meeting will focus on one of the most important aspects of EVs, their role in infectious human diseases. The aim of the proposed conference is to improve our understanding of the mechanisms of this involvement and to evaluate EVs as potential therapeutic targets.

Conference Manager;     Phone: [+441638724137];     Email: admin@fusion-conferences.com

extracellular vesicles, Human Infectious Diseases, microbiology, translational medicine, evs,

Phone: [+49 89 890677 0];     Email: info@cocs.de